- Infinity Pharmaceuticals (NASDAQ:INFI) -22%.
- Ekso Bionics (NASDAQ:EKSO) -21% after stock offering.
- Aeterna Zentaris (NASDAQ:AEZS) -18%.
- Zomedica (NYSEMKT:ZOM) -17% after stock offering.
- Hancock Jaffe Laboratories (NASDAQ:HJLI) -12%.
- Ocugen (NASDAQ:OCGN) -11%, pared down yesterday's gains, Chardan Capital downgraded to Neutral from Buy.
- Cleveland-Cliffs (NYSE:CLF) -11% after share offering.
- Sino-Global Shipping America (NASDAQ:SINO) -10%.
- Nemaura Medical (NASDAQ:NMRD) -9%.
- Super League Gaming (NASDAQ:SLGG) -9% after share sale.
- GeoVax Labs (NASDAQ:GOVX) -10% after stock offering.
- Ideal Power (NASDAQ:IPWR) -8% after stock offering.
- DHT Holdings (NYSE:DHT) -8% on Q4 earnings.
- Option Care Health (NASDAQ:OPCH) -8% after secondary offering.
- Liberty Oilfield Services (NYSE:LBRT) -8% after secondary offering.
- Tuniu (NASDAQ:TOUR) -7%.
- GameStop (NYSE:GME) -7%.
- Hudson Capital (NASDAQ:HUSN) -7%.
- AgeX Therapeutics (NYSEMKT:AGE) -7%.
- InspireMD (NYSEMKT:NSPR) -7%.
- Borr Drilling (NYSE:BORR) -6%.
- CNS Pharmaceuticals (NASDAQ:CNSP) -5%.
- OpGen (NASDAQ:OPGN) -6% on launch of direct offering.
- Synthetic Biologics (NYSEMKT:SYN) -6%.
- Marker Therapeutics (NASDAQ:MRKR) -3%.
- MicroVision (NASDAQ:MVIS) -6%.
- IT Tech Packaging (NYSEMKT:ITP) -6%.